期刊
ORGANIC & BIOMOLECULAR CHEMISTRY
卷 8, 期 21, 页码 4987-4996出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c0ob00372g
关键词
-
资金
- European Union
- German Federal Ministry of Education and Research (BMBF) [Fkz. 0315446]
- European Research Council (ERC)
Targeting glycan-binding receptors is an attractive strategy for cell-specific drug and gene delivery. The C-type lectin asialoglycoprotein receptor (ASGPR) is particularly suitable for liver-specific delivery due to its exclusive expression by parenchymal hepatocytes. In this study, we designed and developed an efficient synthesis of carbohydrate-functionalized beta-cyclodextrins (beta CDs) and liposomes for hepatocyte-specific delivery. For targeting of ASGPR, rhodamine B-loaded beta CDs were functionalized with glycodendrimers. Liposomes were equipped with synthetic glycolipids containing a terminal D-GalNAc residue to mediate binding to ASGPR. Uptake studies in the human hepatocellular carcinoma cell line HepG2 demonstrated that beta CDs and liposomes displaying terminal D-Gal/D-GalNAc residues were preferentially endocytosed. In contrast, uptake of beta CDs and liposomes with terminal D-Man or D-GlcNAc residues was markedly reduced. The D-Gal/D-GalNAcfunctionalized beta CDs and liposomes presented here enable hepatocyte-specific targeting. Gal-functionalized beta CDs are efficient molecular carriers to deliver doxorubicin in vitro into hepatocytes and induce apoptosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据